BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Spineology Inc. Names Donald R. Brattain To Board Of Directors


10/19/2005 5:10:23 PM

STILLWATER, Minn., March 9 /PRNewswire/ -- Spineology Inc. announced today that Donald R. Brattain was elected to the Company's Board of Directors, effective February 25, 2004.

Mr. Brattain is President of Brattain & Associates, LLC, a private company located in Minneapolis. In 1991, prior to founding his investment company, Mr. Brattain acquired Barefoot Grass Lawn Service, which he grew from $3.2 million in annual sales to over $100 million. He guided Barefoot through an LBO and IPO before the sale of the company in 1998. Mr. Brattain has chaired and/or served on the boards of six publicly traded companies, including Orthomet, an orthopedic implant company, and Everest Medical, a laparoscopic medical device company. Mr. Brattain no longer serves on the board of any public company but operates several private companies in which he has a majority ownership.

"Mr. Brattain is a valuable addition to our Board of Directors. His vast experience in raising capital, managing resources and building value in companies, large and small, are important assets that he brings to Spineology," said Douglas E. King, Chief Executive Officer of Spineology.

About Spineology Inc.

Spineology is a developer of proprietary technologies to be manufactured and marketed to the global spine implant market. The company has begun U.S. commercialization of OptiMesh, a bone graft containment and reinforcement system for use in vertebral body (intrabody) defects of the spine.

This press release contains forward-looking statements by Spineology regarding its expectations as to its OptiMesh products and other aspects of its business. Such statements are based on its current expectations and are subject to a number of substantial risks and uncertainties that could cause actual results or timeliness to differ materially from those addressed in the forward-looking statements. Factors that may cause such a difference include, but are not limited to, its history of operating losses and its need for additional funds, as well as the risks and uncertainties in preclinical and clinical trial results, gaining regulatory approvals, scaling-up manufacturing, market acceptance, the sales levels of its products, research and development, competition and other risk factors. Spineology undertakes no obligation to publicly update any forward-looking statements.

Contact: Douglas E. King, Chief Executive Officer, Spineology, 651-351-1011

Spineology Inc.

CONTACT: Douglas E. King, Chief Executive Officer of Spineology, +1-651-351-1011



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES